Chambers Michael Andrew
SEC CIK 1932527 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SRPT | Sarepta Therapeutics, Inc. | Dir | 27.5K | $23.27M | — | 11 | 2022-06-02 | 2026-06-04 |
Most active insiders at SRPT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Estepan Ian Michael | COO | — | $294.2K |
| 2 | Mayo Stephen | Dir | — | $123.2K |
| 3 | Wong Ryan Ho-Yan | CFO | — | — |
| 4 | Rothfuss Cristin | EVP, GC | — | — |
| 5 | Chambers Michael Andrew | Dir | — | — |
| 6 | Rodino-Klapac Louise | Pres, R, D, Tech Ops | — | — |
| 7 | Boor Kathryn Jean | Dir | — | — |
| 8 | Nicaise Claude | Dir | — | — |
| 9 | SEVERINO MICHAEL | CEO, Dir | — | — |
| 10 | Barry Richard | Dir | — | — |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-05 20:02 | 2026-06-04 | SRPT | Sarepta Therapeutics, Inc. | Chambers Michael Andrew | Dir | A - Grant | — | +16.9K | 27.5K | +158% | — | |
| D | 2025-03-11 | 2025-03-10 | SRPT | Sarepta Therapeutics, Inc. | Chambers Michael Andrew | Dir | A - Grant | — | +2,383 | 10.7K | +29% | — |
| MI | 2024-08-20 | 2024-08-16 | SRPT | Sarepta Therapeutics, Inc. | Chambers Michael Andrew | Dir | P - Purchase | $133.80 | +37.0K | 260.1K | +17% | +$4.96M |
| D | 2024-03-05 | 2024-03-01 | SRPT | Sarepta Therapeutics, Inc. | Chambers Michael Andrew | Dir | A - Grant | $0.00 | +1,846 | 8,277 | +29% | $0 |
| MI | 2023-08-15 | 2023-08-14 | SRPT | Sarepta Therapeutics, Inc. | Chambers Michael Andrew | Dir | P - Purchase | $109.47 | +9,979 | 243.0K | +4% | +$1.09M |
| I | 2023-08-14 | 2023-08-11 | SRPT | Sarepta Therapeutics, Inc. | Chambers Michael Andrew | Dir | P - Purchase | $108.05 | +23.7K | 237.0K | +11% | +$2.56M |
| MI | 2023-08-11 | 2023-08-10 | SRPT | Sarepta Therapeutics, Inc. | Chambers Michael Andrew | Dir | P - Purchase | $106.15 | +34.9K | 213.3K | +20% | +$3.70M |
| D | 2023-03-08 | 2023-03-06 | SRPT | Sarepta Therapeutics, Inc. | Chambers Michael Andrew | Dir | A - Grant | $0.00 | +1,523 | 6,431 | +31% | $0 |
| M | 2022-09-15 | 2022-09-14 | SRPT | Sarepta Therapeutics, Inc. | Chambers Michael Andrew | Dir | P - Purchase | $104.43 | +57.1K | 108.2K | +112% | +$5.96M |
| M | 2022-08-22 | 2022-08-19 | SRPT | Sarepta Therapeutics, Inc. | Chambers Michael Andrew | Dir | P - Purchase | $108.28 | +46.2K | 45.0K | New | +$5.00M |
| D | 2022-06-06 | 2022-06-02 | SRPT | Sarepta Therapeutics, Inc. | Chambers Michael Andrew | Dir | A - Grant | $0.00 | +4,908 | 4,908 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations